The Enterprise Value as of December 2025 (TTM) for GlycoNex Incorporation (4168.TWO) is 2.21B

According to GlycoNex Incorporation’s latest financial reports and current stock price. The company's current Enterprise Value is 2.21B. This represents a change of -11.39% compared to the average of 2.50B of the last 4 quarters.

GlycoNex Incorporation (4168.TWO) Historical Enterprise Value (quarterly & annually)

How has 4168.TWO Enterprise Value performed in the past?

The mean historical Enterprise Value of GlycoNex Incorporation over the last ten years is 2.57B. The current 2.21B Enterprise Value has changed 8.52% with respect to the historical average. Over the past ten years (40 quarters), 4168.TWO's Enterprise Value was at its highest in in the March 2023 quarter at 3.45B. The Enterprise Value was at its lowest in in the March 2025 quarter at 2.15B.

GlycoNex Incorporation (4168.TWO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of GlycoNex Incorporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

GlycoNex Incorporation (4168.TWO) Average Enterprise Value

How has 4168.TWO Enterprise Value performed in the past?

The current Enterprise Value of GlycoNex Incorporation (4168.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

GlycoNex Incorporation (4168.TWO) Enterprise Value vs. Peers

How is 4168.TWO’s Enterprise Value compared to its peers?

GlycoNex Incorporation’s Enterprise Value is less than TaiRx, Inc. (2.42B), less than Steminent Biotherapeutics Inc. (2.77B), less than Hcmed (2.28B), less than Intech Biopharm Corporation (3.68B), less than Gwo Xi Stem Cell Applied Technology Co. , Ltd (2.87B), greater than Taiwan Bio Therapeutics Co., Ltd (2.09B), less than Sunny Pharmtech Inc. (2.46B), less than Anti-Microbial Savior BioteQ Co., Ltd (2.48B), less than HeXun Biosciences Co., Ltd. (2.40B), less than Genomics BioSci & Tech. Co.,Ltd. (2.21B),

Build a custom stock screener for GlycoNex Incorporation (4168.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GlycoNex Incorporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

GlycoNex Incorporation (4168.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like GlycoNex Incorporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.